Rhine Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.16 M
as on 17-07-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 28.40%
(FY 2023)
- Profit -33.66%
(FY 2023)
- Ebitda -22.92%
(FY 2023)
- Net Worth 12.12%
(FY 2023)
- Total Assets 7.12%
(FY 2023)
About Rhine Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.16 M, as per Ministry of Corporate Affairs (MCA) records.
Tirunilayi Venugopal, Santhosh Bhaskaran, Rajimon Kolakkal, and Six other members serve as directors at the Company.
- CIN/LLPIN
U24232KL2006PTC019505
- Company No.
019505
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Palakkad, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rhine Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajitkumar Warrior  | Managing Director | 08-Jun-2006 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pudugrammam Vaidyanathan | Director | 08-Jun-2006 | Current |
| Tirunilayi Venugopal | Director | 08-Jun-2006 | Current |
| Santhosh Bhaskaran | Director | 26-Jul-2015 | Current |
| Rajimon Kolakkal | Director | 08-Jun-2006 | Current |
| Porai Raphael | Director | 08-Jun-2006 | Current |
| Reji Joy | Director | 08-Jun-2006 | Current |
Financial Performance of Rhine Life Sciences.
Rhine Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.4% increase. The company also saw a substantial fall in profitability, with a 33.66% decrease in profit. The company's net worth Soared by an impressive increase of 12.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rhine Life Sciences?
In 2022, Rhine Life Sciences had a promoter holding of 64.24% and a public holding of 35.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
R-Vision Eye Hospital Private LimitedActive 5 years 10 monthsTirunilayi Venugopal, Rajimon Kolakkal and 1 more are mutual person
Rhine Biogenics Private LimitedActive 21 years 2 monthsTirunilayi Venugopal, Reji Joy and 3 more are mutual person
Rineus Health Care Company Private LimitedActive 12 years 7 monthsTirunilayi Venugopal, Ajitkumar Warrior and 1 more are mutual person
- Renolife Pharma (India) Private LimitedActive 16 years 1 month
Tirunilayi Venugopal, Ajitkumar Warrior and 1 more are mutual person
- Moselle Drugs And Cosmetics LimitedActive 5 years 11 months
Reji Joy, Pudugrammam Vaidyanathan and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rhine Life Sciences?
Unlock and access historical data on people associated with Rhine Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rhine Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rhine Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
